# FDA 483 - ABS Corporation - January 16, 2026

Source: https://www.keypedia.com/records/483/abs-corporation/b2d54213-2596-436c-84b9-356494154ffa

> FDA 483 for ABS Corporation on January 16, 2026. Product: veterinary. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: ABS Corporation
- Inspection Date: 2026-01-16
- Product Type: veterinary
- Office Name: Division of Human and Animal Food Operations - West II
- Summary: ABS Corporation, an animal drug manufacturer in Omaha, NE, was cited for significant deficiencies across its quality system. The inspection revealed failures in thoroughly investigating out-of-specification results and deviations, inadequate component sampling and testing, and a lack of robust process validation and change control procedures. Additionally, the firm failed to routinely calibrate critical equipment and maintain proper calibration documentation.

## Related Documents

- [483 - 2023-08-11](https://www.keypedia.com/records/483/abs-corporation/1916e3d0-c563-4329-9b34-e8720a35f498)
- [483 - 2023-08-11](https://www.keypedia.com/records/483/abs-corporation/0c623efe-ec90-49e7-a9b8-929266a0b234)

## Related Officers

- [Melissa M. Steiger](https://www.keypedia.com/people/melissa-m-steiger/513a7364-15df-474f-8a8a-b5c4ff1cf59f)

Company: https://www.keypedia.com/companies/abs-corporation/27a5f4ae-a47d-4f3a-9861-a43b9e26df57

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-ii/8851d151-0390-4d17-be66-fd86d12aa6b8